Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)Hiren Mandaliya, Ina Nordman, Mark Jones et al.|Translational Lung Cancer Research|2019Cited by 392
Prognostic importance of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), lymphocyte-monocyte ratio (LMR) and advanced lung cancer inflammation index (ALI) at diagnosis and post treatment in elderly with stage IV NSCLCHiren Mandaliya, Ina Nordman, Mark Jones et al.|Annals of Oncology|2017Cited by 3
Prognostic significance of advanced lung cancer inflammation index (ALI) In untreated and treated stage IV non-small cell lung cancer (NSCLC): An Australian cancer centre experienceHiren Mandaliya, Ina Nordman, Mark Jones et al.|Annals of Oncology|2017Cited by 1
Prognostic significance of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) in untreated and treated stage IV non-small cell lung cancer (NSCLC): An Australian cancer centre experience.Hiren Mandaliya, Ina Nordman, Mark Jones et al.|Journal of Clinical Oncology|2017Cited by 0